JPS5896020A - 肝障害改善薬 - Google Patents

肝障害改善薬

Info

Publication number
JPS5896020A
JPS5896020A JP19439281A JP19439281A JPS5896020A JP S5896020 A JPS5896020 A JP S5896020A JP 19439281 A JP19439281 A JP 19439281A JP 19439281 A JP19439281 A JP 19439281A JP S5896020 A JPS5896020 A JP S5896020A
Authority
JP
Japan
Prior art keywords
pantethine
sulfonic acid
serum
salt
ameliorant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP19439281A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0148883B2 (da
Inventor
Tetsuya Suga
須賀　哲弥
Manabu Katsumata
学 勝俣
Tomoyasu Tashiro
智康 田代
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sogo Pharmaceutical Co Ltd
Original Assignee
Sogo Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sogo Pharmaceutical Co Ltd filed Critical Sogo Pharmaceutical Co Ltd
Priority to JP19439281A priority Critical patent/JPS5896020A/ja
Priority to GB08232874A priority patent/GB2110536B/en
Priority to CH6941/82A priority patent/CH652924A5/fr
Priority to FR8220179A priority patent/FR2517542B1/fr
Priority to IT49605/82A priority patent/IT1149398B/it
Priority to DE19823244806 priority patent/DE3244806A1/de
Publication of JPS5896020A publication Critical patent/JPS5896020A/ja
Priority to US06/598,238 priority patent/US4568683A/en
Publication of JPH0148883B2 publication Critical patent/JPH0148883B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP19439281A 1981-12-04 1981-12-04 肝障害改善薬 Granted JPS5896020A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP19439281A JPS5896020A (ja) 1981-12-04 1981-12-04 肝障害改善薬
GB08232874A GB2110536B (en) 1981-12-04 1982-11-18 Pharmaceutical compositions containing pantetheine-s-sulphonic acid
CH6941/82A CH652924A5 (fr) 1981-12-04 1982-11-30 Produits pharmaceutique ameliorant le metabolisme des lipides.
FR8220179A FR2517542B1 (fr) 1981-12-04 1982-12-02 Medicament pour l'amelioration du metabolisme lipidique
IT49605/82A IT1149398B (it) 1981-12-04 1982-12-02 Farmaco che migliora il metabolismo di lipidi contenente acido pantetei n-s-solfonico
DE19823244806 DE3244806A1 (de) 1981-12-04 1982-12-03 Den lipid-stoffwechsel verbesserndes arzneimittel
US06/598,238 US4568683A (en) 1981-12-04 1984-04-09 Lipid metabolism with pantetheine-S-sulfonic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19439281A JPS5896020A (ja) 1981-12-04 1981-12-04 肝障害改善薬

Publications (2)

Publication Number Publication Date
JPS5896020A true JPS5896020A (ja) 1983-06-07
JPH0148883B2 JPH0148883B2 (da) 1989-10-20

Family

ID=16323825

Family Applications (1)

Application Number Title Priority Date Filing Date
JP19439281A Granted JPS5896020A (ja) 1981-12-04 1981-12-04 肝障害改善薬

Country Status (1)

Country Link
JP (1) JPS5896020A (da)

Also Published As

Publication number Publication date
JPH0148883B2 (da) 1989-10-20

Similar Documents

Publication Publication Date Title
US8389005B2 (en) Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
EP0986376B1 (fr) Utilisation d'un oligosaccharide INHIBITEUR DU FACTEUR Xa EN COMBINAISON AVEC UN ANTIAGREGANT PLAQUETTAIRE pour le traitement de LA THROMBOSE ARTERIELLE
IE59606B1 (en) Pharmaceutical compositions
AU632330B2 (en) Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis
US8361514B2 (en) Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
EP0693926B1 (fr) Nouvelle composition pharmaceutique destinee a la preparation d'une poudre stable contenant, a titre d'ingredient actif, une association d'acide acetylsalicylique et de metoclopramide
EP0132994B1 (en) Compounds for lowering lipid levels
CA1307739C (en) Anti-inflammatory compositions
JPS5869813A (ja) 血清脂質低下剤
US4568683A (en) Lipid metabolism with pantetheine-S-sulfonic acid
US4218471A (en) Process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents
JPS60139618A (ja) 白内障治療薬
US3870792A (en) Certain dihydrophthalizines for treating hemorrhage and thrombosis
JPS63310825A (ja) 医薬に有用な二環式化合物のｎ−イミダゾリル誘導体
JPS5855423A (ja) ベンゾグアナミン類を主成分としする医薬
FR2527078A1 (fr) Compositions pharmaceutiques anti-ulceres
JPH0148883B2 (da)
JPS6341421A (ja) 抗白内障剤
KR100290512B1 (ko) 항염증 효과를 갖는 심황속 식물 제제
JPS5978118A (ja) 血栓症治療および予防剤
US3646213A (en) Compositions and methods for treating depression with combinations of l-3 4-dihydroxyphenylalanine and a hydrazine
JPH04234321A (ja) 血中尿酸量を低下させる方法
JPS58164507A (ja) ジベンゾシクロヘプテニリデン類による免疫変化剤
EP0797444A1 (fr) Trousse pour cycle de traitement de l'osteoporose
Ganesan et al. Polyphloretin phosphate temporarily potentiates prostaglandin E2 on the rat fundus, probably by inhibiting PG15‐hydroxydehydrogenase